U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Selective serotonin reuptake inhibitor response

MedGen UID:
808078
•Concept ID:
CN221268
•
Sign or Symptom
Synonyms: Selective serotonin re-uptake inhibitor response; Selective serotonin reuptake inhibitor toxicity; SSRI response
Drug:
Selective serotonin reuptake inhibitors
MedGen UID:
452467
•Concept ID:
C0360105
•
Pharmacologic Substance
Any agent that increases the extracellular level of the neurotransmitter serotonin (5-HT) by inhibiting its reuptake into the presynaptic cell. Increased level in the synaptic cleft prolongs the action of 5-HT on the postsynaptic receptor. This type of agent is typically used as an antidepressant and in the treatment of anxiety disorders and some personality disorders. They are also typically effective and used in treating some cases of insomnia. [from NCI]
Selective serotonin reuptake inhibitors
 
Genes (locations): CYP2C19 (10q23.33); CYP2D6 (22q13.2)

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  

Professional guidelines

PubMed

The Pharmacological Treatment of Obsessive-Compulsive Disorder.
Pittenger C
Psychiatr Clin North Am 2023 Mar;46(1):107-119. Epub 2023 Jan 4 doi: 10.1016/j.psc.2022.11.005. PMID: 36740347
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents.
Strawn JR, Mills JA, Poweleit EA, Ramsey LB, Croarkin PE
Pharmacotherapy 2023 Jul;43(7):675-690. Epub 2023 Jan 27 doi: 10.1002/phar.2767. PMID: 36651686Free PMC Article
Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders.
Walter HJ, Bukstein OG, Abright AR, Keable H, Ramtekkar U, Ripperger-Suhler J, Rockhill C
J Am Acad Child Adolesc Psychiatry 2020 Oct;59(10):1107-1124. Epub 2020 May 18 doi: 10.1016/j.jaac.2020.05.005. PMID: 32439401

Recent clinical studies

Etiology

Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up.
Serretti A, Zanardi R, Franchini L, Artioli P, Dotoli D, Pirovano A, Smeraldi E
Pharmacogenetics 2004 Sep;14(9):607-13. doi: 10.1097/00008571-200409000-00005. PMID: 15475734

Therapy

Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
Yoshimura R, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Katsuki A, Atake K, Nakamura J
Hum Psychopharmacol 2013 Sep;28(5):466-70. Epub 2013 Jun 30 doi: 10.1002/hup.2333. PMID: 23813968
P-glycoprotein (PGP) polymorphisms and sexual dysfunction in female patients with depression and SSRI-associated sexual side effects.
Bly MJ, Bishop JR, Thomas KL, Ellingrod VL
J Sex Marital Ther 2013;39(3):280-8. Epub 2013 Jan 28 doi: 10.1080/0092623X.2011.615896. PMID: 23356581Free PMC Article
Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics.
Abo R, Hebbring S, Ji Y, Zhu H, Zeng ZB, Batzler A, Jenkins GD, Biernacka J, Snyder K, Drews M, Fiehn O, Fridley B, Schaid D, Kamatani N, Nakamura Y, Kubo M, Mushiroda T, Kaddurah-Daouk R, Mrazek DA, Weinshilboum RM
Pharmacogenet Genomics 2012 Apr;22(4):247-53. doi: 10.1097/FPC.0b013e32835001c9. PMID: 22322242Free PMC Article
Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.
Ji Y, Biernacka J, Snyder K, Drews M, Pelleymounter LL, Colby C, Wang L, Mrazek DA, Weinshilboum RM
Pharmacogenomics J 2012 Feb;12(1):78-85. Epub 2010 Sep 28 doi: 10.1038/tpj.2010.69. PMID: 20877297Free PMC Article
Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies.
Martinez D, Broft A, Laruelle M
Biol Psychiatry 2000 Oct 15;48(8):844-53. doi: 10.1016/s0006-3223(00)00993-8. PMID: 11063979

Prognosis

Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up.
Serretti A, Zanardi R, Franchini L, Artioli P, Dotoli D, Pirovano A, Smeraldi E
Pharmacogenetics 2004 Sep;14(9):607-13. doi: 10.1097/00008571-200409000-00005. PMID: 15475734

Clinical prediction guides

P-glycoprotein (PGP) polymorphisms and sexual dysfunction in female patients with depression and SSRI-associated sexual side effects.
Bly MJ, Bishop JR, Thomas KL, Ellingrod VL
J Sex Marital Ther 2013;39(3):280-8. Epub 2013 Jan 28 doi: 10.1080/0092623X.2011.615896. PMID: 23356581Free PMC Article
Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics.
Abo R, Hebbring S, Ji Y, Zhu H, Zeng ZB, Batzler A, Jenkins GD, Biernacka J, Snyder K, Drews M, Fiehn O, Fridley B, Schaid D, Kamatani N, Nakamura Y, Kubo M, Mushiroda T, Kaddurah-Daouk R, Mrazek DA, Weinshilboum RM
Pharmacogenet Genomics 2012 Apr;22(4):247-53. doi: 10.1097/FPC.0b013e32835001c9. PMID: 22322242Free PMC Article
Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up.
Serretti A, Zanardi R, Franchini L, Artioli P, Dotoli D, Pirovano A, Smeraldi E
Pharmacogenetics 2004 Sep;14(9):607-13. doi: 10.1097/00008571-200409000-00005. PMID: 15475734

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • Gene
      Related information in NCBI Gene
    • GTR
      Related information in GTR
    • GTR(Clinical)
      Clinical tests in GTR
    • OMIM(Genes)
      OMIM records containing genes associated with phenotypes registered in MedGen
    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...